The global regenerative medicine market was valued at $32.1 billion in 2023, and is projected to reach $531.7 Billion by 2033, growing at a CAGR of 32.4% from 2024 to 2033
Report Code : A00298 | Pages : 216 | Category : Life Sciences
The global pain management drugs market was valued at $72.6 billion in 2023, and is projected to reach $109.6 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033
Report Code : A00309 | Pages : 216 | Category : Life Sciences
The global analgesics market was valued at $26.7 billion in 2020, and is projected to reach $50.7 billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.
Report Code : A01063 | Pages : 133 | Category : Life Sciences
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Report Code : A01078 | Pages : 90 | Category : Life Sciences
The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.
Report Code : A01159 | Pages : 280 | Category : Life Sciences
The global antiemetics market was valued at $2.3 billion in 2021, and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.
Report Code : A00336 | Pages : 260 | Category : Life Sciences
The global antipsychotic drugs market size was valued at $12,417.60 million in 2020, and is estimated to reach $26,041.00 million by 2030, growing at a CAGR of 8.0% ...
Report Code : A00338 | Pages : 187 | Category : Life Sciences
The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Report Code : A00381 | Pages : 261 | Category : Life Sciences
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) ...
Report Code : A00402 | Pages : 55 | Category : Life Sciences
The global non small cell lung cancer market was valued at $15.3 billion in 2021, and is projected to reach $36.9 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Report Code : A00544 | Pages : 262 | Category : Life Sciences
